
Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.
Apr 14
58 min

David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.
Mar 31
1 hr 19 min

Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
Mar 16
1 hr 10 min

Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.
Mar 3
1 hr 7 min

Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.
Feb 11
57 min

Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.
Jan 27
1 hr 20 min

Ram Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines.
Jan 13
1 hr 1 min

David Schenkein, general partner at GV, on investing in the future of biotech.
Jan 2
59 min

Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.
Dec 11, 2024
1 hr 2 min

Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.
Nov 25, 2024
1 hr
Load more